{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:00:53Z","timestamp":1780434053098,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/pat.0b013e32835c76e2","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T04:54:03Z","timestamp":1355806443000},"page":"172-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay"],"prefix":"10.1016","volume":"45","author":[{"given":"Meryta L.","family":"May","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Lambkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e32835c76e2_bib0005","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/jcm.35.10.2435-2443.1997","article-title":"Laboratory diagnosis of pertussis: state of the art in 1997","volume":"35","author":"Muller","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.33321\/cdi.2007.31.18","article-title":"B. Pertussis epidemiology in Australia over the decade 1995-2005 - trends by region and age group","volume":"31","author":"Quinn","year":"2007","journal-title":"Commun Dis Intell"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0950268801006598","article-title":"Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection","volume":"128","author":"Poynten","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0020","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1128\/JCM.01371-10","article-title":"Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis","volume":"48","author":"Riffelmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1128\/CVI.05430-11","article-title":"A Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay","volume":"19","author":"May","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0035","series-title":"National Statement on Ethical Conduct in Human Research 2007","first-page":"79","year":"2007"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0040","series-title":"Pertussis Surveillance: A Global Meeting, Geneva, 16-18 October 2000","year":"2001"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0045","series-title":"Australian Immunisation Handbook","first-page":"227","year":"2008"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.33321\/cdi.2010.34.25","article-title":"Immunisation coverage annual report, 2008","volume":"34","author":"Hull","year":"2010","journal-title":"Commun Dis Intell"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0055","series-title":"Requirements for the Development and Use of In-house In Vitro Diagnostic Devices","year":"2007"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0060","series-title":"Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests","first-page":"27","year":"2007"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S0950268804003012","article-title":"The seroepidemiology of Bordetella pertussis infection in Western Europe","volume":"133","author":"Pebody","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/CVI.00372-08","article-title":"Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study","volume":"16","author":"Xing","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0080","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/jcm.31.5.1256-1261.1993","article-title":"Determination of the optimal cutoff value for a serological assay: an example using the Johne\u2019s absorbed ELISA","volume":"31","author":"Ridge","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/422035","article-title":"Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study","volume":"190","author":"Le","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/CVI.05686-11","article-title":"Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?","volume":"19","author":"Pawloski","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0095","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1017\/S0950268809990707","article-title":"The utility of seroepide-miology for tracking trends in pertussis infection","volume":"138","author":"Quinn","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0100","doi-asserted-by":"crossref","first-page":"e27681","DOI":"10.1371\/journal.pone.0027681","article-title":"Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics","volume":"6","author":"Hendrikx","year":"2011","journal-title":"PLoS One"},{"key":"10.1097\/PAT.0b013e32835c76e2_bib0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/PL00015016","article-title":"Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children","volume":"18","author":"Wirsing von Konig","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:18:06Z","timestamp":1758471486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516315835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0031302516315835"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e32835c76e2","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0b013e32835c76e2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}